Steward Partners Investment Advisory’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Steward Partners Investment Advisory’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$825K	Sell	21,257 -202	-0.9%	-$7.08K	﹤0.01%	1411
2026 Q1	$707K	Buy	+21,459	New	+$687K	﹤0.01%	1338

Other funds holding IBRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Steward Partners Investment Advisory's IBRN Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its iShares Neuroscience and Healthcare ETF (IBRN) stake by 0.94% in Q2 2026, selling an estimated $7.08K and leaving 21,257 shares worth $825K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Steward Partners Investment Advisory first reported a position in IBRN in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold IBRN as of Q2 2026.

Steward Partners Investment Advisory held 21,257 shares of iShares Neuroscience and Healthcare ETF worth $825K as of Q2 2026.
Steward Partners Investment Advisory sold 202 iShares Neuroscience and Healthcare ETF shares in Q2 2026, an estimated $7.08K.
iShares Neuroscience and Healthcare ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1411 holding.
Steward Partners Investment Advisory first reported a position in iShares Neuroscience and Healthcare ETF in Q1 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.